BSE filing, NSE: UCAL. Summary written from the filing by ALFA Finder's alert engine.
UCAL Ltd: key numbers
- Share price
- ₹123.30
- Market cap
- ₹272.7 Cr
- Revenue (annual)
- ₹837.8 Cr
- Net profit (annual)
- ₹-33.32 Cr
- P/E (TTM)
- -12.7×Sector 30.9×
- Promoter holding
- 70.28%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UCAL Ltd
All →UCAL Board Meeting Date
UCAL LIMITED has scheduled a board meeting on 30 October 2026 to consider and approve its standalone and consolidated financial results for the half year ended September 2026.
UCAL Other Announcement
UCAL Limited has filed its quarterly compliance certificate under SEBI Regulation 74(5) for the period ended 30th September 2026.
UCAL Annual General Meeting
UCAL Limited successfully conducted its 40th Annual General Meeting on September 29, 2026, to transact the ordinary and special business listed in the AGM notice.
UCAL Legal & Regulatory
Ucal Ltd received a show cause notice from Maharashtra State Tax authorities regarding a GST audit. The notice demands a penalty of ₹0.88 Crore, including interest.
- Value
- ₹0.88 Cr
UCAL Other Announcement
Ucal Limited has issued a communication to shareholders regarding the availability of the FY 2025-26 Annual Report. The company's 40th AGM is scheduled for September 29, 2026.
UCAL Annual Report
UCAL Limited has submitted its Annual Report for the Financial Year 2025-26. The report details the company's operational performance and strategic growth initiatives.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.